Reunion Neuroscience
RE-104, a psilocybin analog molecule for treating postpartum depression and severe mental health disorders
- Sector
- Biotech
- Headquarters
- MORRISTOWN, NJ
- Founded
- 2023
- Latest Form D
- $16.9M, Jan 2024
- Total capital
- $16.9M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $16.9M
- 1 Form D · last Jan 2024
- 33 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 16 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$16.9M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Alon LazarusDirectorNamed in SEC Form D filings
- Ansbert GadickeDirectorNamed in SEC Form D filings
- Edward SmithExecutive OfficerNamed in SEC Form D filings
- Ellen LubmanDirectorNamed in SEC Form D filings
- Gregory MayesExecutive Officer, DirectorNamed in SEC Form D filings
- Mark PollackExecutive OfficerNamed in SEC Form D filings
Show all 10 people
- Mark TheeuwesExecutive OfficerNamed in SEC Form D filings
- Michael EhlersDirectorNamed in SEC Form D filings
- Natalie SacksDirectorNamed in SEC Form D filings
- Nathan BrysonExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 16- PendingBenzyltryptamine CompoundsUSPTOApplication 19179705
- PendingBenzyltryptamine CompoundsUSPTOApplication 19094736
- PendingTryptamine ProdrugsUSPTOApplication 19308120
Show all 16 patent records
- Benzyltryptamine CompoundsMay 21, 2026 · Application 19179705Pending
- Benzyltryptamine CompoundsFeb 12, 2026 · Application 19094736Pending
- Tryptamine ProdrugsDec 18, 2025 · Application 19308120Pending
- Improved Pharmacokinetics of Tryptamine ProdrugsOct 16, 2025 · Application 19251706Pending
- Tryptamine ProdrugsApr 24, 2025 · Application 18902773Pending
- Tryptamine ProdrugsFeb 13, 2025 · Application 18719620Pending
- Novel Benzyltryptamine CompoundsDec 5, 2024 · Application 18644754Pending
- Tryptamine Prodrug Solid FormsApplication 63796103Pending
- Time-release Tryptamine-related Compositions And TreatmentsApplication PCTUS2025038360Pending
- BenzyltryptaminesApplication 63729830Pending
- Treatment Of Adjustment DisorderApplication 63729808Pending
- Tryptamine Prodrug Solid FormsApplication PCTUS2025038374Pending
- Time-release Tryptamine-related Compositions And TreatmentsApplication 63674230Pending
- Tryptamine Prodrug Solid FormsApplication 63674233Pending
- Novel BenzyltryptaminesApplication PCTUS2025058654Pending
- Treatment Of Adjustment DisorderApplication PCTUS2025058655Pending
Related companies, and why
- SPLIT BIOSCIENCES, INC.Similar federal contract value in Biotech · null in contracts
- Frame Technology, Inc.Similar federal contract value in Biotech · null in contracts
- Autonomy Bio Inc.Similar federal contract value in Biotech · null in contracts
- BESPOKE BIOTHERAPEUTICS LLCSimilar federal contract value in Biotech · null in contracts
- Clene Inc.Similar federal contract value in Biotech · null in contracts
- Varigen Biosciences CorporationSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .